Marker Therapeutics, Inc. — Director's Dealing 2004

Feb 17, 2004

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: GENEMAX CORP (GMXX)
CIK: 0001094038
Period of Report: 2003-12-31

Reporting Person: GENEMAX CORP (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2003-12-31	Common Stock $0.001	A	0	—	Acquired	0	Direct
2003-12-31	Common Stock $0.001	D	0	—	Disposed	788333	Direct
2003-12-31	Common Stock $0.001	I	0	—	Disposed	500000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2003-12-31	Warrant	$0.75	A	0	Acquired	2006-05-01	Common Stock (0)	Direct
2003-12-31	Warrant	$1.00	A	0	Acquired	2005-12-01	Common Stock (0)	Direct
2003-07-15	Stock Options	$1.00	J	150000	Disposed		Common Stock (150000)	Direct
2003-12-16	Stock Options	$0.50	A	125000	Acquired	2011-12-16	Common Stock (125000)	Direct

Footnotes

F1: Held of record by Mr. Davidson's two minor children, respectively, over which Mr. Davidson has sole voting and disposition rights.

F2: Pursuant to Mr. Davidson's resignation as the Chief Financial Officer and a director effective April 16, 2003, the 150,000 stock options previously granted to Mr. Davidson were forfeited on July 15, 2003 in accordance with the terms and provisions of the Stock Option Plan.

F3: Granted in accordance with the terms and provisions of the Stock Option Plan dated December 16, 2003, in consideration of services and duties performed.